Overview
Acute panmyelosis with myelofibrosis is a rare and aggressive hematological disorder characterized by rapid bone marrow failure and extensive fibrosis, often leading to severe cytopenias and life-threatening complications such as hemorrhage 1.Diagnosis
Clinical presentation includes pancytopenia, splenomegaly, and bone marrow fibrosis 1.
Histopathological examination of bone marrow biopsy essential to confirm fibrosis and atypical cell morphology 1.
Blood tests reveal significant cytopenias in all cell lines (anemia, thrombocytopenia, neutropenia) 1.
Imaging may show organomegaly indicative of extramedullary hematopoiesis 1.Management
Supportive care is critical, including transfusions for symptomatic anemia and bleeding 1.
Growth factors such as G-CSF may be considered for neutropenia management 1.
No specific curative treatment; management focuses on symptom control and complications 1.
Anticoagulation or antiplatelet therapy may be necessary to prevent hemorrhage in thrombocytopenic patients 1.Special Populations
No specific data provided regarding pregnancy, pediatrics, or elderly populations in the given abstracts 1.
Comorbidities like intracerebral hemorrhage highlight the need for multidisciplinary care in complex cases 1.Key Recommendations
Perform bone marrow biopsy for definitive diagnosis, confirming extensive fibrosis and atypical cellular features (Evidence: Weak 1).
Prioritize supportive care measures including transfusions and growth factor therapy to manage cytopenias (Evidence: Weak 1).
Implement stringent hemorrhage prophylaxis in patients with thrombocytopenia due to high risk of complications (Evidence: Expert opinion 1).References
1 Markel A, Nagler A, Yoffe G, Aboud L, Brook GJ. Acute myelofibrosis with associated intracerebral haemorrhage. Acta haematologica 1986. link